Work

Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease

Year: 2026
Type: article
Study design: Observational Study
Abstract: Sickle cell disease (SCD) is a thrombophilia exacerbated by pregnancy. However, there is not strong evidence for thromboprophylaxis, perhaps because most data addressing pregnancy-related thrombosis in SCD is limited by derivation from administrative datasets. We studied venous thromboembolism (VTE) in a retrospective cohort of pregnant people with SCD who delivered singleton pregnancies at two academic centres between 1990 and 2021. Among 289 pregnancies to 197 SCD subjects, 6% had VTE. We compared characteristics of the first study pregnancy in which a VTE occurred (cases) to the first study pregnancy in subjects without pregnancy-related VTE (controls). Preconception complications associated with VTE were history of VTE (cases: 33% [n = 5/15] vs. controls: 4% [n = 7/182], p < 0.001), acute chest syndrome (ACS) (80% [n = 12/15] vs. 37% [n = 68/182], p = 0.001) and acute care for vaso-occlusive crisis (VOC) in the year before pregnancy (80% [n = 12/15] vs. 43% [n = 70/182], p = 0.006). Prenatal complications associated with VTE were ACS (47% [n = 7/15] vs. 10% [n = 19/182], p < 0.001) and VOC (93% [n = 14/15] vs. 65% [n = 119/182], p = 0.026). Fetal outcomes associated with VTE included gestational age at delivery (median [IQR] 37.0 [34.0-38.1] weeks vs. 38.3 [36.9-39.3], p = 0.004). Studies are needed to establish interventions that attenuate VTE risk and define prophylactic anti-coagulation parameters for this high-risk population.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7233710034
FWCI:
Cites: 46
Cited by:
Related to: 10